Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Marley, Boyd"'
Autor:
Helen H. Moon, Mairead Kearney, Seyed Hamidreza Mahmoudpour, Chiemeka Ike, Valerie Morris, Andrew Rava, Sonia Kim, Haiyan Sun, Marley Boyd, Gabriel Gomez Rey
Publikováno v:
Current Oncology, Vol 31, Iss 9, Pp 5662-5676 (2024)
For patients with locally advanced/metastatic urothelial carcinoma (la/mUC), first-line (1L) treatment with platinum-based chemotherapy (PBC) followed by avelumab 1L maintenance (1LM) is a recommended therapy per treatment guidelines in patients with
Externí odkaz:
https://doaj.org/article/fd15209258c34d0b85a8c67a3f75b1e5
Autor:
David P. Cosgrove, Emily S. Reese, Nicole M. Fulcher, Sarah S. Bobiak, Francois‐Xavier Lamy, Arthur Allignol, Marley Boyd, Seyed H. Mahmoudpour
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4195-4205 (2023)
Abstract Background Limited data are available regarding second‐line (2 L) treatment for advanced or metastatic biliary tract cancers (BTC) in the US real‐world setting. This study explores the rapidly evolving and growing treatment landscape in
Externí odkaz:
https://doaj.org/article/10f58cd416f74acbbc57c8e425ae1b6d
Publikováno v:
Thoracic Cancer, Vol 12, Iss 14, Pp 2055-2064 (2021)
Abstract Aims Adjuvant chemotherapy has been shown to improve survival in patients with completely resected early‐stage non‐small cell lung cancer (NSCLC). This study evaluated real‐world relapse rates and healthcare resource utilization in pat
Externí odkaz:
https://doaj.org/article/854014b6738d46889e0635dfc3dbc79d
Autor:
Charles L. Cowey, Marley Boyd, Kathleen M. Aguilar, April Beeks, Clemens Krepler, Emilie Scherrer
Publikováno v:
Cancer Medicine, Vol 9, Iss 21, Pp 7863-7878 (2020)
Abstract Introduction Anti‐PD‐1 monotherapies (aPD‐1) and BRAF/MEK inhibitors (BRAF/MEKi) changed the BRAF‐mutant advanced melanoma treatment landscape. This study aimed to improve the understanding of real‐world treatment patterns and opti
Externí odkaz:
https://doaj.org/article/ee976dd75d584d12914c8df2bc5510e8
Autor:
Michael Webster-Clark, Alexander P. Keil, Nicholas Robert, Jennifer R. Frytak, Marley Boyd, Til Stürmer, Hanna Sanoff, Daniel Westreich, Jennifer L. Lund
Publikováno v:
JAMA oncology.
ImportanceDelivery of adjuvant chemotherapy can differ substantially between trial and real-world populations. Adherence metrics like relative dose intensity (RDI) cannot capture the timing of modifications and mask differences in the total amount of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58eb11ff16ca443e0d4d92f10b3d0a64
https://pubmed.ncbi.nlm.nih.gov/36227604
https://pubmed.ncbi.nlm.nih.gov/36227604
Autor:
Eric Nadler, Kathleen Aguilar, Chuck Wentworth, Marley Boyd, E. Susan Amirian, Scott Barker, Pearl French, Thomas Wilson, Lisa M. Hess
Publikováno v:
Sarcoma, Vol 2020 (2020)
Introduction. This study was designed to describe demographic and clinical characteristics of patients diagnosed with advanced or metastatic soft tissue sarcoma (STS) and to examine treatment and healthcare resource utilization patterns of this patie
Externí odkaz:
https://doaj.org/article/6add2362eadf47a7ba2212cc08fb486e
Autor:
David P, Cosgrove, Emily S, Reese, Nicole M, Fulcher, Sarah S, Bobiak, Francois-Xavier, Lamy, Arthur, Allignol, Marley, Boyd, Seyed H, Mahmoudpour
Publikováno v:
Cancer Medicine. 12:4195-4205
Limited data are available regarding second-line (2 L) treatment for advanced or metastatic biliary tract cancers (BTC) in the US real-world setting. This study explores the rapidly evolving and growing treatment landscape in the 2 L setting for adva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87ddf45edd70cf9aad58ec18565fc684
https://doi.org/10.1002/cam4.5282
https://doi.org/10.1002/cam4.5282
Autor:
Robert M. Rifkin, Rohan Medhekar, E. Susan Amirian, Kathleen M. Aguilar, Thomas Wilson, Marley Boyd, Khalid Mezzi, Sumeet Panjabi
Publikováno v:
Therapeutic Advances in Hematology, Vol 10 (2019)
Background: Most multiple myeloma (MM) patients ultimately progress, with remission duration decreasing after first relapse. Recently, novel agents have been approved for the treatment of relapsed MM. There is a paucity of real-world data on these tr
Externí odkaz:
https://doaj.org/article/79f21fba59354e9a83f8f6d4f60056f2
Autor:
Nicholas J Robert, Marley Boyd, Shrujal S. Baxi, Aaron B Cohen, Yanina Natanzon, Olga Tymejczyk, Mark Stewart, Laura Lasiter, Elizabeth Garrett-Mayer, Donna R. Rivera, Jeff Allen, Monika A Izano, Eric Hansen, Mackenzie Small, Jennifer B. Christian, Andrew J. Belli, Joseph Wagner, Janet L. Espirito, Connor Sweetnam
Publikováno v:
Clinical Pharmacology & Therapeutics. 111:444-454
In prior work, Friends of Cancer Research convened multiple data partners to establish standardized definitions for oncology real-world end points derived from electronic health records (EHRs) and claims data. Here, we assessed the performance of rea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebac8e31166fd8a9e91525c60d34544a
https://doi.org/10.1002/cpt.2443
https://doi.org/10.1002/cpt.2443
Autor:
Jaffer Ajani, Marley Boyd, Jenifer Wogen, Ilia Ferrusi, Peyman Nakhaei, Lakshmi Menon-Singh, Ailis Fagan
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6673f80a9630a2f6aa4c127d794576e
https://doi.org/10.1136/jitc-2022-sitc2022.0445
https://doi.org/10.1136/jitc-2022-sitc2022.0445